| 51 |
16608847 | PUMA Dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells. | 2006 Jun 9 |
2 |
| 52 |
16749867 | HPMA copolymer-bound doxorubicin induces apoptosis in ovarian carcinoma cells by the disruption of mitochondrial function. | 2006 May-Jun |
1 |
| 53 |
16843435 | p38 MAPK downregulates phosphorylation of Bad in doxorubicin-induced endothelial apoptosis. | 2006 Sep 1 |
1 |
| 54 |
16928273 | Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line. | 2006 Aug 23 |
1 |
| 55 |
17140381 | Changes in expression of genes encoding antioxidant enzymes, heme oxygenase-1, Bcl-2, and Bcl-xl and in level of reactive oxygen species in tumor cells resistant to doxorubicin. | 2006 Nov |
1 |
| 56 |
15781649 | Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. | 2005 Mar 15 |
1 |
| 57 |
15893350 | Effect of antineoplastic drugs on the expression of Bcl-2 and Bcl-xL genes in the feline T-cell leukemia cell line. | 2005 Dec |
2 |
| 58 |
15911101 | Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. | 2005 Jun 16 |
1 |
| 59 |
16280040 | Targeted therapy against Bcl-2-related proteins in breast cancer cells. | 2005 |
1 |
| 60 |
12452453 | Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide. | 2002 Nov |
1 |
| 61 |
11236942 | The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro. | 2001 Feb |
1 |
| 62 |
11313718 | Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells. | 2001 Feb |
1 |
| 63 |
11506966 | Hepatocyte growth factor (HGF) protects c-met-expressing Burkitt's lymphoma cell lines from apoptotic death induced by DNA damaging agents. | 2001 Aug |
1 |
| 64 |
11108797 | Down-regulation of bcr-abl and bcl-x(L) expression in a leukemia cell line and its doxorubicin-resistant variant by topoisomerase II inhibitors. | 2000 Dec 15 |
1 |
| 65 |
10381639 | Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells. | 1999 May |
1 |
| 66 |
9443402 | BCL-X expression in multiple myeloma: possible indicator of chemoresistance. | 1998 Jan 15 |
1 |
| 67 |
9642215 | Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance. | 1998 Jul 3 |
1 |
| 68 |
9766678 | Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. | 1998 Oct 1 |
2 |
| 69 |
7669718 | Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. | 1995 Jun |
1 |